Join to View Full Profile
1275 York AveNew York, NY 10065
Phone+1 212-639-2410
Fax+1 212-772-8521
Dr. Ely is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an accomplished physician and leader with deep expertise in hematopathology and oncology. My work has advanced precision medicine and innovative therapies for cancer. Leveraging years of experience in both academic and industry settings, I have contributed to groundbreaking research, drug development, and the integration of diagnostics into hematology and oncology. I have successfully led large cross-functional teams, collaborated with key stakeholders across the pharma and academic landscapes, fostering partnerships with foundations and patient advocacy organizations to improve patient outcomes. My focus on precision medicine brings together experience and success in asset strategy, conducting clinical trials, laboratory optimization, and biomarker utilization. My work has led to innovations that help drive the future of cancer therapeutics.
Education & Training
Tulane UniversityMPH, 1988 - 1991
Tulane University School of MedicineClass of 1991- Louisiana State UniversityNo degree, 1983 - 1987
- University of London, Queen Mary CollegeNo degree, 1985 - 1986
Certifications & Licensure
NJ State Medical License 2022 - 2027
NY State Medical License 1996 - 2027
CA State Medical License 2022 - 2026
RI State Medical License 2022 - 2026
LA State Medical License 1991 - 1996
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Hematology
Awards, Honors, & Recognition
- First prize, Best Pathology Book of the Year British Medical Association, 2014
- Finalist, Cornell Venture Challenge 2013
- M. Desmond Burke MD Award Weill Cornel, 2012
Clinical Trials
- Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Start of enrollment: 2017 Jan 30
- A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma Start of enrollment: 2015 Nov 23
- Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma Start of enrollment: 2024 Apr 09
Publications & Presentations
PubMed
- Editorial Expression of Concern: Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.Ornella Flore, Shahin Rafii, Scott Ely, John J O'Leary, Elizabeth M Hyjek
Nature. 2025-07-01 - 39 citationsSpatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on...David B Page, Glenn Broeckx, Chowdhury Arif Jahangir, Sara Verbandt, Rajarsi R Gupta
The Journal of Pathology. 2023-08-01 - External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices.Inne Nauwelaers, Nele Laudus, Dieter Peeters, Balazs Acs, Carsten Denkert
Cancers. 2022-08-02
Journal Articles
- Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomasMartin P FR, Rutherford S, Ruan J, Ely S, Greenberg J, Coleman M, Goldenberg DM, Wegener WA, Sharkey RM, Goldsmith SJ, Leonard JP, Leukemia and Lymphoma, 1/1/2015
- "High-grade MALT" vs diffuse large B cell lymphomaEly, SA, Gastroenterology, 1/1/2002
- The distinction between high grade MALT and diffuse large B cell lymphomaEly, S, Gut, 1/1/2002
Books/Book Chapters
Abstracts/Posters
- Fine Needle Aspiration in the Diagnosis of Lymphoma: An Integrated Cytopathologist's and Hematopathologist’s ApproachEly S, American Society of Clinical Pathology Annual Meeting, Los Angeles, CA, 1/30/2015
- Myeloma Treatment (moderator)Ely S, Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignancies, New York, NY, 1/13/2016
- Myeloma Proliferation: a fresh lookEly S, Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignancies, New York, NY, 1/13/2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
